Investigating Ugi/Passerini Multicomponent Reactions for the Site-Selective Conjugation of Native Trastuzumab
- 2 November 2020
- journal article
- research article
- Published by Wiley in Chemistry – A European Journal
- Vol. 26 (61), 13797-13805
- https://doi.org/10.1002/chem.202002432
Abstract
Site-selective modification of proteins has been the object of intense studies over the past decades, especially in the therapeutic field. Prominent results have been obtained with recombinant proteins, for which site-specific conjugation is made possible by the incorporation of particular amino acid residues or peptide sequences. In parallel, methods for the site-selective and site-specific conjugation of native and natural proteins are starting to thrive, allowing the controlled functionalization of various types of amino acid residues. Pursuing the efforts in this field, we planned to develop a new type of site-selective method, aiming at the simultaneous conjugation of two amino acid residues. We reasoned that this should give higher chances of developing a site-selective strategy compared to the great majority of existing methods that solely target a single residue. We opted for the Ugi four-centre three-component reaction to implement this idea, with the aim of conjugating the side-chain amine and carboxylate groups of two neighbouring lysine and aspartate/glutamate. Herein, we show that this strategy can give access to valuable antibody conjugates bearing several different payloads; furthermore, the approach limits the potential conjugation sites to only six on the model antibody trastuzumab.Keywords
Funding Information
- Université de Strasbourg
- Infrastructures en Biologie Santé et Agronomie
- Conseil Régional d'Alsace
- Association Nationale de la Recherche et de la Technologie
This publication has 49 references indexed in Scilit:
- Residue-Specific Peptide Modification: A Chemist’s GuideBiochemistry, 2017
- Current Status: Site-Specific Antibody Drug ConjugatesJournal of Clinical Immunology, 2016
- Lysine conjugation properties in human IgGs studied by integrating high‐resolution native mass spectrometry and bottom‐up proteomicsProteomics, 2015
- Selective chemical protein modificationNature Communications, 2014
- Statistical Modeling of the Drug Load Distribution on Trastuzumab Emtansine (Kadcyla), a Lysine-Linked Antibody Drug ConjugateBioconjugate Chemistry, 2014
- Chemoenzymatic methods for site-specific protein modificationCurrent Opinion in Chemical Biology, 2010
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic indexNature Biotechnology, 2008
- Synthetic Haptens as Probes of Antibody Response and ImmunorecognitionMethods, 2000
- Chemical modifications of proteins: history and applicationsBioconjugate Chemistry, 1990
- Chemistry of the Crosslinking of Collagen during TanningAdvances in experimental medicine and biology, 1977